Business Description
Mycotopia Therapies Inc
NAICS : 541714
SIC : 2836
ISIN : US90138D1072
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | -2.04 | |||||
Debt-to-Equity | -0.38 | |||||
Debt-to-EBITDA | -1.65 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -233.2 | |||||
3-Year EPS without NRI Growth Rate | -330.9 | |||||
3-Year FCF Growth Rate | -91.3 | |||||
3-Year Book Growth Rate | -414.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.74 | |||||
9-Day RSI | 40.73 | |||||
14-Day RSI | 39.73 | |||||
6-1 Month Momentum % | -45 | |||||
12-1 Month Momentum % | -45 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.04 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | -471.15 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -100.33 | |||||
ROIC % | -32.04 | |||||
ROC (Joel Greenblatt) % | -132600 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.88 | |||||
EV-to-EBITDA | -1.52 | |||||
EV-to-FCF | -4.06 | |||||
Earnings Yield (Greenblatt) % | -113.64 | |||||
FCF Yield % | -315.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TPIA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mycotopia Therapies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.14 | ||
Beta | 2.2 | ||
Volatility % | 460.5 | ||
14-Day RSI | 39.73 | ||
14-Day ATR ($) | 0.001737 | ||
20-Day SMA ($) | 0.018375 | ||
12-1 Month Momentum % | -45 | ||
52-Week Range ($) | 0.01 - 0.1799 | ||
Shares Outstanding (Mil) | 5.99 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mycotopia Therapies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mycotopia Therapies Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Mycotopia Therapies Inc Frequently Asked Questions
What is Mycotopia Therapies Inc(TPIA)'s stock price today?
When is next earnings date of Mycotopia Therapies Inc(TPIA)?
Does Mycotopia Therapies Inc(TPIA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |